A detailed history of Brandywine Global Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 1,152,580 shares of ABBV stock, worth $202 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares
1,152,580
Previous 950,206 21.3%
Holding current value
$202 Million
Previous $163 Million 39.66%
% of portfolio
1.6%
Previous 1.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $33.2 Million - $40.3 Million
202,374 Added 21.3%
1,152,580 $228 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $14.4 Million - $16.8 Million
92,868 Added 10.83%
950,206 $163 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $3.13 Million - $3.57 Million
-19,606 Reduced 2.24%
857,338 $156 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $5.74 Million - $6.46 Million
-41,704 Reduced 4.54%
876,944 $136 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $7.71 Million - $8.93 Million
-57,724 Reduced 5.91%
918,648 $137 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $17.9 Million - $22.3 Million
-135,373 Reduced 12.18%
976,372 $132 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $5.18 Million - $5.97 Million
-35,844 Reduced 3.12%
1,111,745 $177 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $840,094 - $1.01 Million
6,074 Added 0.53%
1,147,589 $186 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $2.73 Million - $3.13 Million
-20,342 Reduced 1.75%
1,141,515 $153 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $11.6 Million - $14.8 Million
-84,631 Reduced 6.79%
1,161,857 $178 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $35 Million - $43.5 Million
-265,390 Reduced 17.55%
1,246,488 $202 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $39.3 Million - $49.7 Million
365,992 Added 31.94%
1,511,878 $205 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $102 Million - $116 Million
958,493 Added 511.49%
1,145,886 $124 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $34,614 - $38,562
-329 Reduced 0.18%
187,393 $21.1 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $553,443 - $609,274
5,410 Added 2.97%
187,722 $20.3 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $448,731 - $605,835
5,575 Added 3.15%
182,312 $19.5 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $177,318 - $208,113
-2,064 Reduced 1.15%
176,737 $15.5 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $10.5 Million - $14.1 Million
-143,340 Reduced 44.5%
178,801 $17.6 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $17.4 Million - $26.4 Million
-270,309 Reduced 45.63%
322,141 $24.5 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $4.09 Million - $5.12 Million
-56,736 Reduced 8.74%
592,450 $53.1 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $34.2 Million - $41.2 Million
-543,586 Reduced 45.57%
649,186 $49.2 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $1.31 Million - $1.68 Million
19,965 Added 1.7%
1,192,772 $86.7 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $2.02 Million - $2.38 Million
26,197 Added 2.28%
1,172,807 $94.5 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $26.5 Million - $32.7 Million
-340,269 Reduced 22.88%
1,146,610 $106 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $22.6 Million - $25.2 Million
-254,609 Reduced 14.62%
1,486,879 $141 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $6.83 Million - $8.09 Million
76,116 Added 4.57%
1,741,488 $161 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $46.7 Million - $62.6 Million
-507,778 Reduced 23.37%
1,665,372 $158 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $13 Million - $14.3 Million
145,302 Added 7.17%
2,173,150 $210 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $8.25 Million - $10.5 Million
-118,081 Reduced 5.5%
2,027,848 $180 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,145,929
2,145,929 $156 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.